Filing Analysis

📄 Other SEC Filing Filed May 21, 2026
⚪ LOW

Harte Hanks, Inc. reported the voting results from its 2026 Annual Meeting of Stockholders held on May 21, 2026. Stockholders elected four board nominees, approved executive compensation on an advisory basis, and ratified the appointment of Wolf & Company P.C. as the independent auditor for fiscal year 2026.

📋 Key Facts

  • The 2026 Annual Meeting of Stockholders was held on May 21, 2026.
  • Four board nominees (Genni Combes, John H. Griffin, Jr., Bradley Radoff, and Elizabeth Ross) were elected to serve until the next annual meeting.
  • Executive compensation was approved on a non-binding advisory basis with 4,875,115 votes For, 246,517 Against, and 1,536 Abstain.
  • The selection of Wolf & Company P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified with 5,506,650 votes For.
📢 Regulation FD Disclosure Filed May 14, 2026
⚪ LOW

Harte Hanks, Inc. announced its financial results for the first quarter ended March 31, 2026, via a press release. The filing serves as a standard quarterly earnings disclosure furnished to the SEC.

📋 Key Facts

  • Financial results for the quarter ended March 31, 2026, were released on May 14, 2026.
  • The information was furnished under Item 2.02 and is not considered 'filed' for liability purposes.
  • Exhibit 99.1 contains the full text of the earnings press release.
📢 Regulation FD Disclosure Filed Mar 18, 2026
⚪ LOW

Harte Hanks, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The results were disclosed via a press release furnished as an exhibit to the filing.

📋 Key Facts

  • The report was filed on March 17, 2026, covering the period ending December 31, 2025.
  • The company furnished the earnings information under Item 2.02 (Results of Operations and Financial Condition).
  • Exhibit 99.1 contains the full text of the press release regarding the fiscal 2025 financial results.
  • The filing was signed by David Garrison, the Chief Financial Officer.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for HHS

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial